1 – 10 of 270
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2025
- Immune checkpoint inhibitors in gynecologic cancer : getting to prime T(I)ME? (2025)
- 2024
- VIMAP-trial : vulvar cancer intra-operative margin assessment using PET-CT (2024) ESGO 2024 Congress, Abstracts.
- Exclusion of non-involved uterus from the target volume (EXIT-trial) : an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by completion surgery (2024) CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 47.
- Sexual health in Belgian cervical cancer survivors : an exploratory qualitative study (2024) QUALITY OF LIFE RESEARCH. 33(5). p.1401-1414
- Performance of MRI for detection of ≥pT1b disease in local staging of endometrial cancer (2024) CANCERS. 16(6).
- Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study (vol 72, pg 475, 2022) (2024) CANCER IMMUNOLOGY IMMUNOTHERAPY. 74(1).
- Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial (2024) GYNECOLOGIC ONCOLOGY. 191. p.275-286
- BIMAP : breast cancer intra-operative margin assessment using PET-CT (2024) ESMO OPEN. In ESMO Open 9(Supplement 4).
- Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases : results from a randomized trial in ovarian cancer (2024) BRITISH JOURNAL OF SURGERY. 111(4).
- Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study (2024) NPJ PRECISION ONCOLOGY. 8(1).